These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33631417)

  • 1. Generation and cardiac differentiation of an induced pluripotent stem cell line from a patient with arrhythmia-induced cardiomyopathy.
    Rebs S; Beier J; Argyriou L; Schill T; Hasenfuss G; Vollmann D; Sossalla S; Streckfuss-Bömeke K
    Stem Cell Res; 2021 May; 53():102263. PubMed ID: 33631417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease Modeling and Disease Gene Discovery in Cardiomyopathies: A Molecular Study of Induced Pluripotent Stem Cell Generated Cardiomyocytes.
    Kumar S; Curran JE; Kumar K; DeLeon E; Leandro AC; Peralta J; Williams-Blangero S; Blangero J
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of an induced pluripotent stem cell line from a Chinese Han child with arrhythmia.
    Hou C; Liu W; Xie L; Zheng J; Chen X; Sun X; Zhang Y; Xu M; Li Y; Xiao T
    Stem Cell Res; 2021 Mar; 51():102183. PubMed ID: 33497884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Induced Pluripotent Stem-Cell-Derived Cardiomyocytes as Models for Genetic Cardiomyopathies.
    Brodehl A; Ebbinghaus H; Deutsch MA; Gummert J; Gärtner A; Ratnavadivel S; Milting H
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31489928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of a human induced pluripotent stem cell line (UALGi001-A) from a patient with Left-Ventricular Noncompaction Cardiomyopathy.
    Calado SM; Bento D; Justino D; Mendes-Silva L; Marques N; Bragança J
    Stem Cell Res; 2021 May; 53():102302. PubMed ID: 33799278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of Functional Cardiomyocytes from the Synoviocytes of Patients with Rheumatoid Arthritis via Induced Pluripotent Stem Cells.
    Lee J; Jung SM; Ebert AD; Wu H; Diecke S; Kim Y; Yi H; Park SH; Ju JH
    Sci Rep; 2016 Sep; 6():32669. PubMed ID: 27609119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-Specific and Gene-Corrected Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Short QT Syndrome.
    Guo F; Sun Y; Wang X; Wang H; Wang J; Gong T; Chen X; Zhang P; Su L; Fu G; Su J; Yang S; Lai R; Jiang C; Liang P
    Circ Res; 2019 Jan; 124(1):66-78. PubMed ID: 30582453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and cardiac differentiation of a human induced pluripotent stem cell line UALGi002-A from a female patient with Left-Ventricular Noncompaction Cardiomyopathy.
    Calado SM; Bento D; Marques N; Bragança J
    Stem Cell Res; 2021 Aug; 55():102462. PubMed ID: 34280889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of somatic cell sources in the maturation degree of human induced pluripotent stem cell-derived cardiomyocytes.
    Pianezzi E; Altomare C; Bolis S; Balbi C; Torre T; Rinaldi A; Camici GG; Barile L; Vassalli G
    Biochim Biophys Acta Mol Cell Res; 2020 Mar; 1867(3):118538. PubMed ID: 31472168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Untangling the Biology of Genetic Cardiomyopathies with Pluripotent Stem Cell Disease Models.
    Buikema JW; Wu SM
    Curr Cardiol Rep; 2017 Apr; 19(4):30. PubMed ID: 28315121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced Pluripotent Stem Cell-Derived Cardiomyocytes from a Patient with MYL2-R58Q-Mediated Apical Hypertrophic Cardiomyopathy Show Hypertrophy, Myofibrillar Disarray, and Calcium Perturbations.
    Zhou W; Bos JM; Ye D; Tester DJ; Hrstka S; Maleszewski JJ; Ommen SR; Nishimura RA; Schaff HV; Kim CS; Ackerman MJ
    J Cardiovasc Transl Res; 2019 Oct; 12(5):394-403. PubMed ID: 30796699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe DCM phenotype of patient harboring RBM20 mutation S635A can be modeled by patient-specific induced pluripotent stem cell-derived cardiomyocytes.
    Streckfuss-Bömeke K; Tiburcy M; Fomin A; Luo X; Li W; Fischer C; Özcelik C; Perrot A; Sossalla S; Haas J; Vidal RO; Rebs S; Khadjeh S; Meder B; Bonn S; Linke WA; Zimmermann WH; Hasenfuss G; Guan K
    J Mol Cell Cardiol; 2017 Dec; 113():9-21. PubMed ID: 28941705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling Nonischemic Genetic Cardiomyopathies Using Induced Pluripotent Stem Cells.
    Khedro T; Duran JM; Adler ED
    Curr Cardiol Rep; 2022 Jun; 24(6):631-644. PubMed ID: 35657495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced pluripotent stem cells in the inherited cardiomyopathies: From disease mechanisms to novel therapies.
    Ross SB; Fraser ST; Semsarian C
    Trends Cardiovasc Med; 2016 Nov; 26(8):663-672. PubMed ID: 27296521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiological abnormalities in induced pluripotent stem cell-derived cardiomyocytes generated from Duchenne muscular dystrophy patients.
    Eisen B; Ben Jehuda R; Cuttitta AJ; Mekies LN; Shemer Y; Baskin P; Reiter I; Willi L; Freimark D; Gherghiceanu M; Monserrat L; Scherr M; Hilfiker-Kleiner D; Arad M; Michele DE; Binah O
    J Cell Mol Med; 2019 Mar; 23(3):2125-2135. PubMed ID: 30618214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Derivation of human induced pluripotent stem cell line EURACi004-A from skin fibroblasts of a patient with Arrhythmogenic Cardiomyopathy carrying the heterozygous PKP2 mutation c.2569_3018del50.
    Ermon B; Volpato CB; Cattelan G; Silipigni R; Di Segni M; Cantaloni C; Casella M; Pramstaller PP; Pompilio G; Sommariva E; Meraviglia V; Rossini A
    Stem Cell Res; 2018 Oct; 32():78-82. PubMed ID: 30219716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Generation of induced pluripotent stem cells from arrhythmogenic right ventricular disease patient].
    Jiang B; Wang GQ; Li HX; Jiang WP; Chen T; Jiang Y
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 Jun; 33(6):503-507. PubMed ID: 29931898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A human pluripotent stem cell model of catecholaminergic polymorphic ventricular tachycardia recapitulates patient-specific drug responses.
    Preininger MK; Jha R; Maxwell JT; Wu Q; Singh M; Wang B; Dalal A; Mceachin ZT; Rossoll W; Hales CM; Fischbach PS; Wagner MB; Xu C
    Dis Model Mech; 2016 Sep; 9(9):927-39. PubMed ID: 27491078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of Fabry cardiomyopathy model for drug screening using induced pluripotent stem cell-derived cardiomyocytes from a female Fabry patient.
    Kuramoto Y; Naito AT; Tojo H; Sakai T; Ito M; Shibamoto M; Nakagawa A; Higo T; Okada K; Yamaguchi T; Lee JK; Miyagawa S; Sawa Y; Sakata Y; Komuro I
    J Mol Cell Cardiol; 2018 Aug; 121():256-265. PubMed ID: 30048710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of two-pore K
    Chai S; Wan X; Nassal DM; Liu H; Moravec CS; Ramirez-Navarro A; Deschênes I
    Am J Physiol Heart Circ Physiol; 2017 Jun; 312(6):H1144-H1153. PubMed ID: 28341634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.